Venus Concept Announces Third Quarter and First Nine Months of 2020 Financial Results
TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Month: November 2020
Crinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China
SALT LAKE CITY, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics...
MediPharm Labs Reports Third Quarter 2020 Results
BARRIE, Ontario, Nov. 16, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or...
Masimo to Present in Stifel Virtual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Stifel Virtual Healthcare Conference...
Model N’s Fall 2020 Release for High Tech Offers Expanded AI/ML, Price Optimization and Channel Network Features
Model N introduces new revenue management and channel performance solutions with enhanced AI/ML reach for deal and channel intelligence SAN...
InterVenn Biosciences Raises $34M to Commercialize Glycoproteomic LDT for Ovarian Cancer and Immuno-oncology; taps John Leite, Ph.D., as Chief Business Officer
Company looks to validate first of its kind LDTs intended for immediate clinical use and drive rapidly expanding partnership projects...
Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform
NEW YORK & MORRISTOWN, N.J.--(BUSINESS WIRE)--Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its...
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2020 Financial Results
Day-90 Analysis of FX-322 Phase 2a Study for Acquired Sensorineural Hearing Loss (SNHL) Planned for Late Q1 2021; End of...
Grapefruit USA, Inc. Reports 677% Revenue Growth Year-Over-Year; 48% Revenue Growth QuarterOver-Quarter, Margins Expand; CEO Recaps Overall Incredible Quarter
LOS ANGELES, CA and DESERT HOT SPRINGS, CA / ACCESSWIRE / November 16, 2020 / Grapefruit USA, Inc., ("GPFT", "Grapefruit"...
Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients
Patient Blood Management with Masimo SpHb Increased Transfusion Appropriateness and Decreased RBC Units Transfused per Patient NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ:...
IHF LLC Adds New Terpenes to Their Online Store
As the Colorado operations continue to expand its scope and product lines, terpenes are among the areas where new products...
Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
-- Maintained efficacy and greatly reduced anti-VEGF treatment burden after a single IVT injection of ADVM-022 -- -- Robust preliminary aqueous...
RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...
VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
CAMPBELL, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- On November 10, 2020, VIVUS, Inc. (the “Company”), a biopharmaceutical company, filed the...
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose...
Diabetes Freedom Reviews – Diabetes Reversal Solution Diabetes Freedom By James Freeman Analyzed
Diabetes Freedom reviews by James Freeman. Diabetes reversal type 2 diabetes freedom program truth and facts. The eBook any good?...
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease * ...
Pacific Health Care Organization, Inc. Reports Third Quarter 2020 Results
Newport Beach, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed...
BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company...